Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
10.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
QT IMAGING Aktie jetzt für 0€ handeln | |||||
31.03. | QT Imaging Holdings GAAP EPS of -$0.15 | 1 | Seeking Alpha | ||
31.03. | QT IMAGING HOLDINGS, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
31.03. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
28.02. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
27.02. | QT Imaging receives $10.1M in new funding | 1 | Seeking Alpha | ||
12.02. | QT IMAGING HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
05.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.02.2025 | 848 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.02.2025ISIN NameCA75525M1095 RAZOR... ► Artikel lesen | |
31.01. | QT IMAGING HOLDINGS, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
24.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
16.01. | QT Imaging files to sell 8.81M shares of common stock for holders | 1 | Seeking Alpha | ||
16.01. | QT IMAGING HOLDINGS, INC. - S-1, General form for registration of securities | - | SEC Filings | ||
13.01. | QT Imaging sichert finanzielle Grundlage und prognostiziert Wachstum | 1 | Investing.com Deutsch | ||
10.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
20.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
12.12.24 | QT Imaging announces new commercial shipment in partnership with Couri Center | 1 | Seeking Alpha | ||
11.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
13.11.24 | QT Imaging Holdings GAAP EPS of -$0.17, revenue of $0.96M | 3 | Seeking Alpha | ||
13.11.24 | QT Imaging Announces Third Quarter 2024 Financial Results | 175 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 446,60 | +0,01 % | Opening Bell: Tesla, Enphase Energy, Intuitive Surgical, Boeing, Apple, Meta, Bitcoin, Strategy | Der Optimismus verfestigt sich langsam an den US-Börsen. Gestern legten die großen Indizes bereits deutlich zu. Heute deuten sich die nächsten Gewinne an. Gleichzeitig müssen die Märkte aber auch viele... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,133 | +0,76 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,639 | -0,93 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast... ► Artikel lesen | |
PING AN HEALTHCARE | 0,800 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,012 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,312 | -0,64 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,972 | -4,14 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
VERU | 0,468 | -3,70 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
VOLITIONRX | 0,482 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
EKSO BIONICS | 0,360 | -4,76 % | Ekso Bionics Holdings, Inc.: Bionic P&O Chosen as First Distributor of Ekso Indego Personal Within the Orthotics & Prosthetics Industry | ||
IMUNON | 0,795 | +1,27 % | Imunon, Inc.: IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting | ||
BEYOND AIR | 0,190 | +3,26 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
NOVACYT | 0,453 | +1,46 % | Novacyt legt Termin für Finanzergebnisse 2024 fest |